[CUE] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 8.62%
YoY- 7.46%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 1,717 187 1,000 1,553 900 370 0 -
PBT -12,347 -13,109 -14,255 -12,505 -12,818 -11,267 -7,523 8.59%
Tax 806 99 17 0 -203 -114 0 -
NP -12,347 -13,208 -14,272 -12,505 -12,818 -11,267 -7,523 8.59%
Tax Rate - - - - - - - -
Total Cost 14,064 13,395 15,272 14,058 13,718 11,637 7,523 10.98%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -719.10 -7,063.10 -1,427.20 -805.22 -1,424.22 -3,045.14 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.25 -0.30 -0.44 -0.41 -0.48 -0.54 -0.37 -6.31%
EPS Diluted -0.25 -0.30 -0.44 -0.41 -0.48 -0.54 -0.37 -6.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.